Sansure Biotech Inc (688289) — Cash Flow Reinvestment Rate
Sansure Biotech Inc (688289) has a Cash Flow Reinvestment Rate of 1.06x as of September 2025, reinvesting CN¥63.08 Million (capex CN¥63.08 Million ) from operating cash flow of CN¥59.72 Million. Explore Sansure Biotech Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Sansure Biotech Inc across 8 annual periods. Also explore Sansure Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sansure Biotech Inc (2018–2025)
Year-by-year capital reinvestment analysis for Sansure Biotech Inc. For live market cap and broader valuation context, see how much is Sansure Biotech Inc worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.12x | CN¥573.17 Million | CN¥183.96 Million | CN¥369.77 Million | ▲ +7.0% |
| 2024 | 2.91x | CN¥799.38 Million | CN¥274.45 Million | CN¥421.10 Million | ▼ -81.6% |
| 2023 | 15.86x | CN¥1.79 Billion | CN¥112.82 Million | CN¥391.35 Million | ▲ +2251.7% |
| 2022 | 0.67x | CN¥1.73 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -14.8% |
| 2021 | 0.79x | CN¥1.49 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▲ +14.6% |
| 2020 | 0.69x | CN¥1.82 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▼ -88.0% |
| 2019 | 5.75x | CN¥128.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +75.8% |
| 2018 | 3.27x | CN¥32.90 Million | CN¥10.07 Million | CN¥32.90 Million | — |